KEROS THERAPEUTICS INC (KROS) Stock Income Statement
NASDAQ:KROS • US4923271013
Current stock price
10.68 USD
+0.07 (+0.66%)
At close:
10.73 USD
+0.05 (+0.47%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 244.06M | 3.55M | 151.00K | 0.00 | 20.10M | |||
| Operating Expenses | 173.49M | 214.38M | 170.09M | 114.79M | 76.47M | |||
| Research and Development | 127.14M | 173.63M | 135.26M | 87.27M | 55.14M | |||
| Selling, General, and Administrative Expenses | 46.35M | 40.75M | 34.83M | 27.53M | 21.33M | |||
| Operating Income | 70.57M | -210.83M | -169.94M | -114.79M | -56.37M | |||
| Interest Income/Expense | 24.87M | 23.50M | 14.76M | 0.00 | 0.00 | |||
| Other Income/Expense | -539.00K | 284.00K | 2.19M | 10.11M | -360.00K | |||
| Non Recurring Items | -3.00M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 91.90M | -187.05M | -152.99M | -104.68M | -56.73M | |||
| Income Tax | 4.88M | 300.00K | 0.00 | 0.00 | 2.01M | |||
| Net Income | 87.01M | -187.35M | -152.99M | -104.68M | -58.74M | |||
| EBITDA | 72.08M | -209.60M | -169.13M | -114.12M | -55.99M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.30 | -5.00 | -5.20 | -4.15 | -2.52 | |||
| Non GAAP EPS | 1.82 | -5.01 | -5.20 | -4.15 | -2.52 | |||
| Statistics | ||||||||
| Profit Margin | 35.65% | -5277.55% | -101319.21% | N/A | -292.24% | |||
| Operating Profit Margin | 28.91% | -5938.96% | -112543.71% | N/A | -280.45% | |||
All data in USD